AGEN

Agenus (AGEN)

About Agenus (AGEN)

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Details

Daily high

$3.68

Daily low

$3.43

Price at open

$3.53

52 Week High

$19.69

52 Week Low

$2.50

Market cap

82.3M

Dividend yield

0.00%

Volume

256,712

Avg. volume

448,531

P/E ratio

-.32

Agenus News